Morrison Jodie Pope
CIK: 0001618247•CEO
OfficerDirector
Primary company: Novus Therapeutics, Inc. (NVUS)
Morrison Jodie Pope is a corporate insider (CEO) at Novus Therapeutics, Inc. (NVUS) filing SEC Form 4 transactions. 64 transactions across 6 companies, totaling $0 in purchases and $489,137 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Q32 Bio Inc. QTTB | Award | 132,000 | - | - | 353,104 | 7/16/2026 Filed: 7/16/2026 | Filing → |
Q32 Bio Inc. QTTB | Sale | 9,896 | $4.51 | $45K | 89,104 | 2/25/2026 Filed: 2/25/2026 | Filing → |
Q32 Bio Inc. QTTB | Award | 132,000 | - | - | 221,104 | 2/24/2026 Filed: 2/24/2026 | Filing → |
Q32 Bio Inc. QTTB | Sale | 22,506 | $3.46 | $78K | 99,000 | 12/2/2025 Filed: 12/4/2025 | Filing → |
Q32 Bio Inc. QTTB | Sale | 10,494 | $1.80 | $19K | 121,506 | 8/26/2025 Filed: 8/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 42,200 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 267,541 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 42,200 | - | - | 42,200 | 6/5/2025 Filed: 6/6/2025 | Filing → |
Q32 Bio Inc. QTTB | Award | 394,445 | $2.54 | $1.00M | 394,445 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Disposition | 394,445 | $16.82 | $6.63M | 0 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Award | 16,901 | $2.54 | $43K | 16,901 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Disposition | 16,901 | $17.08 | $289K | 0 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Award | 152,700 | $2.54 | $388K | 152,700 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Disposition | 152,700 | $7.50 | $1.15M | 0 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Award | 152,700 | $2.54 | $388K | 152,700 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Disposition | 152,700 | $7.50 | $1.15M | 0 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Q32 Bio Inc. QTTB | Award | 132,000 | - | - | 132,000 | 2/24/2025 Filed: 2/26/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 267,541 | - | - | 267,541 | 6/26/2024 Filed: 6/28/2024 | Filing → |
Q32 Bio Inc. QTTB | Award | 394,445 | - | - | 394,445 | 3/25/2024 Filed: 3/27/2024 | Filing → |
AILERON THERAPEUTICS INC ALRN | Award | 54,500 | $0.00 | $0 | 54,500 | 6/15/2022 Filed: 6/17/2022 | Filing → |
Q32 Bio Inc.
QTTB
Type
Award
Shares
132,000
Price
-
Value
-
Q32 Bio Inc.
QTTB
Type
Sale
Shares
9,896
Price
$4.51
Value
$45K
Q32 Bio Inc.
QTTB
Type
Award
Shares
132,000
Price
-
Value
-
Q32 Bio Inc.
QTTB
Type
Sale
Shares
22,506
Price
$3.46
Value
$78K
Q32 Bio Inc.
QTTB
Type
Sale
Shares
10,494
Price
$1.80
Value
$19K
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
42,200
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
267,541
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Award
Shares
42,200
Price
-
Value
-
Q32 Bio Inc.
QTTB
Type
Award
Shares
394,445
Price
$2.54
Value
$1.00M
Q32 Bio Inc.
QTTB
Type
Disposition
Shares
394,445
Price
$16.82
Value
$6.63M
Q32 Bio Inc.
QTTB
Type
Award
Shares
16,901
Price
$2.54
Value
$43K
Q32 Bio Inc.
QTTB
Type
Disposition
Shares
16,901
Price
$17.08
Value
$289K
Q32 Bio Inc.
QTTB
Type
Award
Shares
152,700
Price
$2.54
Value
$388K
Q32 Bio Inc.
QTTB
Type
Disposition
Shares
152,700
Price
$7.50
Value
$1.15M
Q32 Bio Inc.
QTTB
Type
Award
Shares
152,700
Price
$2.54
Value
$388K
Q32 Bio Inc.
QTTB
Type
Disposition
Shares
152,700
Price
$7.50
Value
$1.15M
Q32 Bio Inc.
QTTB
Type
Award
Shares
132,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Award
Shares
267,541
Price
-
Value
-
Q32 Bio Inc.
QTTB
Type
Award
Shares
394,445
Price
-
Value
-
AILERON THERAPEUTICS INC
ALRN
Type
Award
Shares
54,500
Price
$0.00
Value
$0
AI Agent
Try asking...